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ABSTRACT mine the decay cu rve pa rameters from which the h alf-life of leptin 
Conscious female ad ult lean a nd obese Zu cker ra ts were injected (5.46 ::!: 0.23 mi n for lean rats a nd 6.99 ::!: 0.75 min for obese ra ts) a s 
through the j ugul ar vein with radioactive iodine-labeled murine lep­ well as the size ofi ts circulating pool (32 pmol/kg for lean ra ts and 267 
tin ; in the en su ing 8 min , four blood samples were sequ en ti a lly ex­ pmol/kg for obes e r ats) a nd the overall degradation r ate (96 fka t/kg 
tracted from the carot id artery. The sa mpl es were use d in a modified for lea n rats and 645 fkat/k g for obese rats) were es timated . The se 
RIA for lep ti n , in whic h pa ired tu bes received the sa me a mo un t of val ues are cons is tent with the hor monal ro le of lep tin and the ne ed 
eith er labeled or unl a beled le ptin , th us allowing us to estimate both for speed y ch anges in its levels in r espon se to m eta bolic cha llenge . 
lept in levels a nd s peci fic radioa ctivity . Th e dat a were used to deter- (Endocrinology 139: 4466-4469 , 1998 ) 
L EPTIN, the product of the ob gen e (1), is a key factor in the regula tion of bod y weight. Its precise ro le, how­
ever, has been subject to open controve rsy and di scu ssion (2) 
desp ite earlier claims th at its main ro le was that of a pon­
dero stat signal, able in itself to modify the ene rgy pa rtition 
in some strains of ro den ts (3). A large amo un t of resea rch has 
been carried ou t to estab lish the functions of leptin (4, 5) since 
its di scovery in 1994 (1), bu t our knowled ge of its in vivo 
d ynamics is sketchy , in part because of methodological d if­
ficul ty and in pa rt because of the priority given to even tua l 
pharmaco log ical use an d the need to cha racterize the mech ­
an ism s regulating its expression and signal ing role. 
The kinet ic ana lysis of circ ulating horm ones is a goo d 
source of in format ion abo u t th e theoretical speed of resp onse 
to change as well as on the demand for syn thesis and / or 
de grada tion that the living or ganism devotes to the main­
tenance of a full y functiona l and resp on sive sys tem . Sho rt 
half-lives repr esent a high er ene rgy expenditure but allow 
for faster resp ons es and more immediate adaptati on ; lon ger 
turnover rates are usually correlated wi th longer term reg­
ulatory activity . Leptin turnover has been estimated in hu­
ma ns (ha lf-life of abo ut 25 min) (6) using arterio-ven ous 
diff erences and in mice (half-live s of 1.5-3 h) (7, 8) by mea­
suring the de cay of circula ting label after the inject ion of 
labeled leptin. 
Our me thod for the est im ation of circu la ting pepti de hor­
mone turnove r rat es in vivo, w hich we have appl ied to insulin 
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(9), has the advan tages that only the label in the imm uno­
reactive pe ptide horm on e is taken into account, an d all the 
measurem ents are performed in a single an imal. 
We chose the hyperlep tinemic Zucker Jalfa rat, because of 
overexpressio n of the ob gene (10), to test w he ther this ove r­
expression affects the turnover rate of leptin. The ma in ob­
jective, however, was to dete rmine the range of the half-life 
of circul ating lep tin to elucidate th e p redo mina nce of its 
short or long term metabolic actions. 
Materials and Methods 
Material s and animals 
Pure recom bin ant m urine lepti n (Bio trend, Koln, German y) and 1251_ 
labeled murine lep tin (specific radioactivi ty, 69.2 GBql f.lmOl; Anawa, 
Zurich, Sw itzerland) were used. The labe led lep tin used ha s a chro­
ma tog raphic pur ity of 98.6%. 
Zucker lean (Fa/?) and obese (ja/ja) female ad ult ra ts, we ighing 224 ::!: 
4 and 398 ::!: 19 g, respe ctively, bre d at the Animal Servic e of the Uni­
versi ty of Barce lona (Barcelona, Spain) from he tero zygous stock ob­
tained from Cha rles River Labo rato ries, Inc. (Wilming ton, MA), we re 
used . The an im als wer e housed in ind ividual polypropylene-bottomed 
cages under s tandard cond itions (ligh ts on from 0800 - 2000 h; 22-23 C; 
70-75% relative hum id ity), an d w ere fed stan dard chow pe llets (type 
A04, Panlab, Barcelona, Spain). A series of four rat s of each phenotyp e 
w as cann ulated, under eth yl ether anesthesia , in the left caro tid artery 
(bringing the tip of the cannu la jus t to the hear t) with P-50 and in the 
right jugular vein w ith p olO polye thy lene tubes (Clay-Ada ms, Pa rsip ­
pany, NJ). The can nu las were filled w ith heparinized saline an d sealed ; 
they were th readed sc. exiting the ra t throu gh the back, wher e they were 
coiled an d held in pl ace w ith surgical tape. The rats we re used for the 
experimen ts 5 h late r. At the end of the expe rimen t, the rats we re killed 
by decap ita tion. This study was con d ucted in accord ance w ith Eu rope an 
Com munity p rinciples, guidelines, and p roce d ure s for an imal 
experimentation. 
Lep tin turnover measurement 
Th e experimen t w as beg un (6 h after the beginn ing of the ligh t cycle) 
by in jecting each rat (within 5-8 sec) th rou gh the jugul ar venous cann ula 
with 80 kBq (1.16 pmol) labe led lepti n in 0.2 ml isotonic saline solution. 
The rad ioactivity initially p resent (and th at remaining after the injection) 
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in the sy ringe wa s me asured with a y-cou n ter. At timed in terval s of 1, 
2, 5, an d 8 min, ali quots of 0.4 m l blood wer e ext racte d through the 
caro tid cannu la and stor ed a t 4 C in hepari nized plastic via ls. The blood 
samples w ere immediate ly cen trifug ed a t 4 C to separate the pl asma 
sam ples, wh ich we re used directly fo r labeled leptin esti mation and 
leptin turnover acco rding to ou r metho d for insulin turnover (9) mod ­
ified for us e w ith leptin. The rat was main tained cons ciou s and un aware 
of the mani pula tions (except for the uncoiling of the cannulas), as it 
rema ined in its cage out of sight of the researchers throughout the 
experiment. 
Plasma lep tin levels wer e es tima ted usi ng a s tandard RIA procedure 
(Linco Research, Inc., St . Charles, MO ) w ith some mod ifica tions: ea ch 
plasma samp le w as distrib uted in two tubes; in the first, in add ition to 
the p,lasma samp le [100 p.l (lean) or 40 p.l (obesej], 100 -160 p.l buffer, 100 
p.l t 51-la beled lep tin solu tion cont aining 0.43 kBq (i.e. 6.25 frnol ), and 100 
p.l diluted spe cific lep tin antibody (L inco Resear ch) w ere added . In the 
rema ining tube, the p lasma samples [loa p.l (lean) or 40 p.l (obe se)] 
recei ved 100- 160 p.1buffe r, 100 p.l u nlab ele d murine lep tin (6.25 frn ol), 
and 100 p.l specific lept in antibody. Thus, the second tube fina lly con­
tained the same am ount of lep tin as the first (the am ou nt initially p resent 
and that added were the same as those in the first tub e), but the amount 
of labeled lept in presen t in either was different; the second tu be lacked 
the added labeled lep tin used for the st and ard RIA procedure. Since the 
to tal am ount of lep tin wa s the sa me in both se ries of tu bes , the lab eled 
leptin initially present in plasm a bound in the same propor tion to the 
antibody pr eparation; thus, the second tube cou ld be used as a b lank for 
the first as in a standard RIA procedure. Th is a llowed es tima tion of the 
ap parent leptin concentration regardless of the amoun t an d d ist ribut ion 
in molecular sp ecies of rad ioacti v ity initially p resent in the pla sm a. This 
approach circumve nted the problems posed by the presence of rad io­
active sources (lep tin an d other) in the samples. Th e RIA wa s completed 
wi th a series of standards of m urine lep tin , bla nks, and several tubes for 
the estima tion of non specific bind ing. All measuremen ts we re carried 
ou t in dup lica te for each an imal and time poi nt. 
Calculations 
The lept in label pr esent in a give n sa mple of p lasma wa s es tima ted 
ass um ing tha t labeled lept in w as bo und by the antibod y in the same 
proportion as un labeled leptin from the same source. From the RIA dat a, 
a p lot of lept in bound to the an tibody us. the concentra tion of lepti n in 
the tube wa s d rawn using murine leptin as a stan dard . Th e da ta were 
fitted to an as ymmetric sigmoid cu rve u sin g the FiC- P program (Biosof r, 
Cambrid ge, UK); the calculated paramet ers of the curve were used to 
estima te the pe rcen tage of lep tin bo und to each of the blood samples 
ob tained in the exper iment. Thi s percentage also reflected the proportion 
of lept in rad ioacti v ity bound to the an tibod y; th us, the total amount of 
lepti n rad ioactivity, 1'" pe r m l blood at a given time, t, wa s est ab lish ed 
for each samp le. The 1', va lues were plotted agai nst time t a nd fitted to 
a standard decay graph us ing the FiC-P prog ram: r, = 1'0 X e- K x '". from 
which, K the deca y cons tant, and reY the ini tial radi oactivity per ml 
blood , were obtained . The half-li fe, t1 / 2, o f leptin wa s ca lcula ted from K, 
since t 1/ 2 = 1 IK.Th e ra tio of total ra d ioactivity injected, Ro l 1'0' wa s used 
to establ ish the vo lume, V, o f di stribution of the injected label (i.e. the 
vir tual or pr act ical leptin space): V = Ral ro. The content of leptin was 
calcu late d from tot alleptin rad ioac tivity an d the sp ecific activit y of the 
labeled leptin injec ted . Injected leptin was a ma ximum of 16% (lean ) to 
1% (obese) of the tot al body lept in. As this proportion w as small, its 
inf luen ce on circula ting lep tin was minimal. The rat leptin concentration 
in plasma di d no t vary du ring the experiment.The conce ntra tion 1IS. tim e 
graphs w ere used to obta in a mean Ieptin concen tra tion value, 1M , and 
to check whether ther e w ere significant va ria tions in lep tin concen tra­
tion. As we kn ew both the virtual d istribu tion volume and the concen­
tra tions , we cou ld derive the whole ma ss of circul ating lep tin La a t time 
zero: Lo = 1M X V. The ra te of loss of leptin (ra te of degr ada tion, 0) from 
this circulating pool could be derived from the decay cu rve an d the mass 
of lept in : 0 = K x La. Indeed, as the virtu al di st ribution vo lume, V, did 
not change, the lept in ma ss at a g iven tim e, L" can be es tima ted from 
the plasma concen tra tions, I" and the degrad atio n ra tes for di fferent 
times, 0" may be calcula ted . The va lues obta ined in all cases w ere ve ry 
simila r, beca use the cha nges in leptin concentration during the 8-min 
analys is w ere insignificant. 
The loss of radioactivity from the labeled leptin pool was stud ied by 
est ablishing the to tal le ptin label val ues, R" a t a given time fro m the 
rad ioac tivity per ml p lasma and the virtual volume of distrib ution : R, 
= 1', X V. 
Statis tica l compar ison be twe en groups wa s es tablished with st and ard 
ANOVA programs and Student' s t test. 
Results 
Plasma leptin levels were maintained within a ma ximal 
ran ge of varia tion of 6 ::'::: 2% (lean ) and 20 ::'::: 7% (obese) of 
the ini tial va lues in the time elapsed between the injection 
and the las t blood ext racti on. The signifi cances of the effect 
of time on leptin conce ntrations we re P = 0.968 (lean ) and 
P = 0.250 (obese ; by ANOVA). 
Figure 1 presents the decay curves for pl asma leptin ra­
dioactivity V5. time. Lean and obese ra ts sh owed a sim ilar 
pattern over time. The d ifferences betwe en both se ries of 
animals were sign ificant, as was the effect of tim e. These 
decay curves were used for the calcula tion of lept in space, 
tu rn over rates, an d cleavage, shown in Table 1. Leptin level s 
were higher in the obes e rats than in the lean ra ts . The 
d istribution space of leptin was lar ger for the larger obese 
rats, but was com parab le for both groups when the data were 
corrected for body size despite the smaller re lative lean body 
mass of the obese rats. 
Obese ra ts had a high er leptin mass than lean con tro ls; th is 
wa s maintained even after correcting for bo dy size. The 
half-life of leptin w as in the same ran ge for lean and obese 
rats; the latter showed somewha t lon ger ( ~ 28 %) half-li ves. 
The calculated lepti n degradation ra tes were almost 7-fold 
higher in obese rats tha n in the lean (pe r U bod y ma ss). 
Discussion 
The m ethod used here has been previously successfully 
used for the an alysi s of insulin turnover in lean and obese 
rats (9). It is con ceptually simple, bu t requires a careful de ­
velopmen t, especially at the cri tica l point of eva luation of 
lep tin rad ioacti vity in the samples . The injection of lab eled 
lep tin did not sig nifican tly a ffect the mass of circulat ing 
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F IG. 1. Leptin radioac tivity decay with t ime in t he plasma of Zucker 
lean a nd obes e rats injected wit h lab el ed lep t in . Th e data a re the 
m ean z SEM offour or five different an imals and are expresse d a s the 
fract ion of the injected radioa ct ivi ty remain in g in t he whole circ u­
la t ing lep tin pool a t a given time. S ta tistical analys is of the differ en ces 
between groups (by ANOVA): lean us. obese, P = 0.004; effect of t ime 
on lean , P = 0.000; effect of time on obese , P = 0.000. 
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TABLE 1. Comp arison of injected labeled leptin turnover in conscious lean and obese Zucker rat s 
Parameter Units Lean rats P" Obese rats Obese/lean ratio 
Plasma leptin nM 0.4 2 :!: 0.04 < 0.05 3.35 :: 0.23 7.98 
Lep tin virt ual vol of ml 16 .88 :: 1.55 < 0.05 31.57 :': 2.21 1.87 
distribution % ofBW 7.49 :: 0.56 NS 7.9 2 ::: 0 .29 1.06 
Leptin pool mas s pmo l 7.17 :!: 1.32 0.05 107 :: 13 14.9 
pmol/kg BW 31.7 :!: 5.4 0.05 267 :: 23 8.41 
Leptin t'h min 5.46 :!: 0.23 NS 6.99 :: 0.75 1.28 
Rate of leptin remo val/synthesis fkat 21.5 .,. 3. 1 < 0.05 259 ± 32 12.0 
fkat/kg BW 95 .5 :!: 12.4 < 0.05 645 :!: 51 6.76 
The data are th e mean:!: SEM of four or five animals in each gro up . See Materia ls and Methods for th e calculations and derived magnitudes. 
a Significan ce of the differences between lean a nd obese groups was determined by Student's t test. NS . P > 0.05 . 
of the injection of labeled lep tin and remained uniform in all 
of the blood extractio ns. An additiona l advantage of th is 
me thod was its use of rela tively undisturbed animals. 
A cri tica l point in the investigatio n of lep tin cleavage is the 
ass ignment of radioactivity measurements to intact (i.e. func­
tional) leptin, without in terference by free iod ine or other 
labeled pep tid e fra gments eventua lly freed by the cleavage 
of leptin. Leptin tu rnover es timations calcu lated from the 
decay of label in the blood (7,8) tend to give longer half-lives. 
The method used here is not affected by th is interfe re nce , as 
only the label bo und to lep tin is measured; free iodine and 
labeled peptides are removed d uring the RIA proced ure . 
Only lab eled (com p lete) lep tin is bound to the an tibody, an d 
thus only this rad ioactive molecu lar species is taken into 
account. 
The main difficu lty th at may ari se from a st udy based on 
calcula ted constants taken from calcu lated values an d used 
to derive the final results is a cumula tive effect o f residua ls 
in calculat ions, which may lead to err ors. This st udy has been 
de signed to m in im ize th is effec t. The adequacy of decay 
curve fitting is apparen t in Fig. 1, wh ich shows the loss of 
radioactive lep tin in plasma. The low d ispersion of da ta 
suggests an acceptab le degree of precision in the deriva tion 
of the virtua l vo lume of diffusion and decay rates shown in 
Tabl e 1. 
The vi rtual vo lume of d ist ribution of lep tin derived from 
data of ar terial blo od may no t be real, because we do not 
know whether the leptin levels are rep resenta tive; neverthe­
less, the data are useful and admi t comparison between 
differen t animals and situa tions. The lept in pool size, L, is 
more reliable, because it is derived d irectly from decay 
curves and lep tin levels . Leptin pool size was much higher 
in obese th an in lean rats bo th in absolute terms and in 
relation to body weight; in the latter case, th e d ifferences 
dimi nished, p robably because of th e d ilu tion effect of th e 
large fat mass in obese rats. Th e relative unifo rm ity of the 
v irtua l volume of dis tribution vs. body weight in lea n and 
obese rats suggested th at the dis trib u tions of lep tin are com­
parable in lean and fat tissu es. As a consequ en ce, the com­
pa risons between both groups were directly referred to body 
size to establish comparisons despite their different body 
weights . 
The turnover ra tes found here are much shorter than those 
found in normal mice (3 h ) (7) or in db/db and ob/ob mice (1.5 
h) (8) calculat ed from label decay curves, and they are also 
shor ter than those estimated in humans from ar ter io-venous 
differences (25 min) (6). These di fferences may be a con se­
quence of th e me tho dology applied; in our case , the circu­
lating levels of lep tin were no t modified, and only leptin label 
was taken into acco unt. The timing of samp le extraction w as 
also in the range of th e measured turnover, which gave 
higher precision to our estimat ions. 
The Zucker fa/fa rats ar e hyperlept inemic, but this lep tin is 
inoperative because they lack a functional hypothalamic lep­
tin recep tor (10, 11). Thi s deficiency has been postulated as 
th e cause of their obesity, becau se it de p rives the ra t of a key 
eleme nt in the contro l of energy pa r tition (12). The white 
adipose tissue of fa/fa ra ts overexpresses the ob gene, thus 
inducing massive sy nthesis of lep tin (10). The syn thesis of 
lep tin in Zucker obese rats is further enhanced by their large 
fat mass, as lep tin production has been fou nd to be related 
to ad ipose tiss ue mass in humans and rodents (13, 14). How­
ever, the half- life of lep tin is in a similar range in lean and 
obese rats; the latter show a mere 28% h igh er mean rate. As 
the lep tin pool size is much larger in the obese ra ts, the 
main tenance of similar tu rnover rates im plies a more ac tive 
degrading process in these animals than in the con trols. We 
have no clear idea where th is lep tin is de gr aded . Some re­
ports suggest that the kidney plays a significant role in th e 
clearan ce of exce ss lep tin from the blood (15, 16). Lean and 
obese Zucker rats do not show different kidney blood flows 
(our unpublished res ults) , but the m uch higher concentration 
of leptin in the bloo d of th e obese rats may be a key factor 
facilita ting its removal; th e mean ratio of pl asma concentra­
tions (obese/lean) is 4.12, and that of the pool removal rates 
is 6.17 (3.49 when corrected fo r body size ). 
As th e levels of lept in in un d isturbed anima ls are un iform, 
it may be assumed that the removal ra te is essen tia lly iden ­
tical to the syn thes is rate of lep tin . This means that a 225-g 
lea n rat sy nthesizes (and d egrades) about 30 p.,g lep tin/ day 
(i.e. 260-fold the whole bo dy lept in mass), much less (a mere 
8%) than that of a 400-g obese rat (358 p.,g / day, i.e. 210-fold 
th e leptin mass). 
The d ifferences between lean and obese rat s found fo r 
leptin were fairly similar to tho se for insulin in this same 
anim al model of obes ity . Zucker fa/fa rats are hyperinsuline­
m ic (17) and show insulin turnover rates similar to those of 
con trols (9). The range of t}/ 2 was also similar be tween leptin 
and ins ulin (only a few minutes) . This va lue is consis ten t 
wi th the ho rmonal ro le of lept in and th e eventual need for 
speedy changes in its levels as a response to metabolic cha l­
lenge, such as th at found under starvation (18), d iet (19, 20), 
or hormonal manipu lation (21), an d may help explain the 
ultradian rhythms of thi s hormone (22). 
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